Zobrazeno 1 - 7
of 7
pro vyhledávání: '"D'souza JW"'
Autor:
Marks, James, D'Souza, JW, Reddy, S, Goldsmith, LE, Shchaveleva, I, Marks, JD, Litwin, S, Robinson, MK
Publikováno v:
Marks, James; D'Souza, JW; Reddy, S; Goldsmith, LE; Shchaveleva, I; Marks, JD; et al.(2014). Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4n995452
© 2014 D'Souza et al.Background: Inappropriate signaling through the epidermal growth factor receptor family (EGFR1/ERBB1, ERBB2/HER2, ERBB3/HER3, and ERBB4/HER4) of receptor tyrosine kinases leads to unregulated activation of multiple downstream si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d2e5309ae07135af088627e78c234bec
http://www.escholarship.org/uc/item/4n995452
http://www.escholarship.org/uc/item/4n995452
Autor:
Nishihori T; Moffitt Cancer Center, Tampa, FL., Hoffman JE; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL., Huff A; GlaxoSmithKline, Collegeville, PA., Kapoor GS; GlaxoSmithKline, Collegeville, PA., Eleftheriadou I; GlaxoSmithKline, Collegeville, PA., Zajic S; GlaxoSmithKline, Collegeville, PA., Urbano A; GlaxoSmithKline, Collegeville, PA., Suchindran S; GlaxoSmithKline, Collegeville, PA., Chisamore M; Merck & Co, Inc, Rahway, NJ., D'Souza JW; GlaxoSmithKline, Collegeville, PA., Faitg T; GlaxoSmithKline, Collegeville, PA., Rapoport AP; University of Maryland Greenebaum Comprehensive Cancer Center and School of Medicine, Baltimore, MD.
Publikováno v:
Blood advances [Blood Adv] 2023 Apr 11; Vol. 7 (7), pp. 1168-1177.
Autor:
Goel N; Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., D'Souza JW; Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Ruth KJ; Department of Biostatistics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Milestone B; Department of Radiology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Karachristos A; Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Nagarathinam R; Department of Pathology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Cooper H; Department of Pathology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Hoffman J; Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA., Reddy S; Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Publikováno v:
Journal of oncology [J Oncol] 2018 Aug 13; Vol. 2018, pp. 7675262. Date of Electronic Publication: 2018 Aug 13 (Print Publication: 2018).
Autor:
D'Souza JW; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hensley H; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Doss M; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Nuclear Medicine, Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and., Beigarten C; ImaginAb Inc., Inglewood, California., Torgov M; ImaginAb Inc., Inglewood, California., Olafsen T; ImaginAb Inc., Inglewood, California., Yu JQ; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; Nuclear Medicine, Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and., Robinson MK; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania matthew.robinson@fccc.edu.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Jan; Vol. 58 (1), pp. 175-180. Date of Electronic Publication: 2016 Aug 18.
Autor:
D'Souza JW; Fox Chase Cancer Center, Molecular Therapeutics Program , Philadelphia, PA 19111 , USA matthew.robinson@fccc.edu., Robinson MK
Publikováno v:
Expert opinion on biological therapy [Expert Opin Biol Ther] 2015 Jul; Vol. 15 (7), pp. 1015-21. Date of Electronic Publication: 2015 May 02.
Autor:
D'Souza JW; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Reddy S; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Goldsmith LE; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Shchaveleva I; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Marks JD; Department of Anesthesia and Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America., Litwin S; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Robinson MK; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America.
Publikováno v:
PloS one [PLoS One] 2014 Nov 11; Vol. 9 (11), pp. e112376. Date of Electronic Publication: 2014 Nov 11 (Print Publication: 2014).
Autor:
Edelstein MV; Institute of Antimicrobial Chemotherapy, Smolensk State Medical Academy, Smolensk, Russia., Skleenova EN, Shevchenko OV, D'souza JW, Tapalski DV, Azizov IS, Sukhorukova MV, Pavlukov RA, Kozlov RS, Toleman MA, Walsh TR
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2013 Oct; Vol. 13 (10), pp. 867-76. Date of Electronic Publication: 2013 Jul 09.